Apogee Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Apogee Therapeutics, Inc. (APGE) reported Increase (Decrease) in Accounts Payable of $1.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-10
- Apogee Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $1.84M, a 42.99% decline year-over-year.
- Apogee Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $16.00K, a 98.84% decline year-over-year.
- Apogee Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $845.00K.
- Apogee Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$5.30M.
- Apogee Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2025 was $150.00K.
- Apogee Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$1.07M, a 166.46% decline from fiscal 2023.
- Apogee Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.61M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 5 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 8 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 11 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.86M 10-Q · filed 2026-08-10 | $2.70M derived: sum of 3 quarters · filed 2026-08-10 | -$2.60M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | $16.00K 10-Q · filed 2026-05-11 | $861.00K derived: sum of 2 quarters · filed 2026-05-11 | -$4.44M derived: sum of 3 quarters · filed 2026-05-11 | -$1.21M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | $845.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$4.46M derived: sum of 2 quarters · filed 2026-03-02 | -$1.22M derived: sum of 3 quarters · filed 2026-08-10 | $150.00K 10-K · filed 2026-03-02 | |||
| 2025-09-30 | -$5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.07M derived: sum of 2 quarters · filed 2026-08-10 | -$695.00K 10-Q · filed 2025-11-10 | -$1.84M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $4.61M 10-Q · filed 2026-08-10 | $3.46M derived: sum of 3 quarters · filed 2026-08-10 | $151.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | $1.37M 10-Q · filed 2026-05-11 | $229.00K derived: sum of 2 quarters · filed 2026-05-11 | -$3.08M derived: sum of 3 quarters · filed 2026-05-11 | -$1.86M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$4.46M derived: sum of 2 quarters · filed 2026-03-02 | -$3.23M derived: sum of 3 quarters · filed 2026-03-02 | -$1.07M 10-K · filed 2026-03-02 | |||
| 2024-09-30 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.09M derived: sum of 2 quarters · filed 2025-11-10 | $73.00K 10-Q · filed 2025-11-10 | $1.11M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $3.38M 10-Q · filed 2025-08-11 | $4.42M derived: sum of 3 quarters · filed 2026-03-02 | -$5.34M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | $2.16M 10-Q · filed 2025-05-12 | $3.19M derived: sum of 2 quarters · filed 2026-03-02 | -$6.57M derived: sum of 3 quarters · filed 2026-03-02 | $3.29M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2023-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$8.73M derived: sum of 2 quarters · filed 2026-03-02 | $1.14M derived: sum of 3 quarters · filed 2026-03-02 | $1.61M 10-K · filed 2026-03-02 | |||
| 2023-09-30 | -$9.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $100.00K derived: sum of 2 quarters · filed 2024-11-12 | $577.00K 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | $9.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $10.34M 10-Q · filed 2024-08-12 | |||||
| 2023-03-31 | $477.00K 10-Q · filed 2024-05-13 | ||||||
| 2022-12-31 | $418.00K 10-K · filed 2024-03-05 | ||||||
| 2022-09-30 | $36.00K 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | $1.11M 10-Q · filed 2023-08-28 |